Business Description
Regen BioPharma Inc. is a California-based biotechnology company founded in 2012 that works to develop new treatments for cancer and autoimmune diseases by targeting a gene known as NR2F6, which plays a key role in regulating immune cell activity. The company is building a pipeline of therapies that use the body's own immune cells, re-engineered through advanced genetic techniques, to either attack tumors or calm an overactive immune system. Its work spans several treatment approaches, including cell-based therapies, gene-silencing tools, and modified immune cells designed to be more effective and longer-lasting.
